Single Peptides · Exact presentation
Semax · 5 mg Vial
Semax · 5 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Separate commercial record
Availability in the Dominican Republic
This educational entry is separate from the live catalog. Check the exact commercial record for current availability, price, and lot documentation. View exact commercial record.
Dosing & Reconstitution Guide
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Semax 5 mg Nasal Spray Calculations
Semax · 5 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
How to Prepare the 5 mL or 10 mL Research Bottle
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Research Amount to Spray Equivalents
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Published Human Intranasal Semax Research
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Published Human Intranasal Semax Research
| Source | Research Context | Published Intranasal Amount and Formulation |
|---|---|---|
| Kaplan et al., 1996[1] | Healthy volunteers in operator and EEG experiments | Experiments included 0.25 mg and 1 mg exposures. The operator experiment reported 1 mg in 0.4 mL physiological solution. |
| Lebedeva et al., 2018[2] | Healthy volunteer fMRI study | One 1.2 mg exposure using a 1% solution, with 60 microliters placed into each nostril. |
| Gusev et al., 2018[3] | Condition-specific post-stroke research | 6,000 mcg per day for 10 days, followed by a second 10-day course after a 20-day interval. |
| Official 0.1% Semax instructions[4] | Registered intranasal drop formulation | 1 mg/mL in purified water with methylparaben. Each 0.05 mL drop contained 50 mcg. |
Nasal Spray Actuator Math
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Core Formula
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Actuator Checks Before Recording a Result
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Research Amount Calculator
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How Intranasal Semax Research Works
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Human Research Findings and Observations
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Research Controls That Affect Nasal Delivery
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Nasal Actuator Technique
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Semax · 5 mg Vial entrysecondary-structure
- PubMed — literature search for Semaxprimary-discovery
- ClinicalTrials.gov — study search for Semaxtrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference